Ambulatory Capacity Measure derived from the Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)
Objective: (1) Construct a measure of ambulatory capacity derived from the MDS-UPDRS that is similarly structured to the original Ambulatory Capacity Measure (ACM) derived from…Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT-10)
Objective: To develop and validate a severity and disability self-administered scale for orthostatic tremor (OT). Background: OT is characterized by a 13-18 Hz tremor in…Developing A Novel Disease-Specific Psychosis Severity Scale in Parkinson’s disease (Psy-PD): A Pilot Study
Objective: To develop and assess the psychometrics of a disease-specific psychosis severity rating scale (Psy-PD) for a one-stop assessment of change in psychotic symptoms in…Survival in restless legs syndrome: An eleven-year surveillance, community-based population study
Objective: To investigate survival in patients with restless legs syndrome (RLS). Background: Previous studies have generated inconsistent results regarding whether RLS is associated with higher…Bruxism Associated with Restless Limbs Syndrome (RLS): A Dopamine Responsive Movement Disorder
Objective: To investigate a possible association of restless limbs syndrome (RLS) and bruxism and determine if bruxism is improved by dopamine agonists (DAs). Background: Bruxism…High prevalence of REM sleep behavior disorder (RBD) in advanced, fluctuating Parkinson’s disease (PD) patients: comparison of clinical parameters between PD patients with and without RBD
Objective: The aim of this study was to investigate the prevalence of RBD in advanced PD patients and to compare the clinical characteristics of advanced…Lack of sensitivity of full-depth upper gastrointestinal specimens as a prodromal biomarker for synucleinopathy in idiopathic REM sleep behavior disorder
Objective: To examine the phosphorylated alpha-synuclein (pAS) immunohistochemistry of the upper gastrointestinal (GI) tract tissue as a “prodromal” pathologic biomarker for synucleinopathy in idiopathic rapid…Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder
Objective: To elucidate longitudinal changes in the dopamine transporter (DAT) availability in idiopathic rapid-eye-movement sleep behavior disorder (iRBD) patients predicted by the baseline motor and…China’s Jidong Restless Legs Syndrome Cohort Study: Objectives, Design, and Baseline Screening
Objective: The authors supposed, restless legs syndrome . partly results from cardiovascular and cerebrovascular disease, and further more, results in the sexual functional changes. Background:…SNCA hypomethylation in rapid eye movement sleep behavior disorder is a potential biomarker for Parkinson’s disease
Objective: We aimed to explore whether there were different distributions of α-synuclein at a genetic and/or protein level in patients with iRBD. Background: α-Synuclein has been related to…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.